teva-english-logo-gray-web-5-1
Photo: Courtesy of Teva
23 March 2017Big Pharma

Teva and generics in SPC win against MSD

The English High Court has ruled that a supplementary protection certificate (SPC) owned by Merck Sharp & Dohme (MSD) is invalid because it didn’t comply with European regulations.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
13 September 2017   Medical device firm Cooper Companies has agreed to acquire the global rights to Teva’s Paragard intrauterine device (IUD) for $1.1 billion.

More on this story

Americas
13 September 2017   Medical device firm Cooper Companies has agreed to acquire the global rights to Teva’s Paragard intrauterine device (IUD) for $1.1 billion.

More on this story

Americas
13 September 2017   Medical device firm Cooper Companies has agreed to acquire the global rights to Teva’s Paragard intrauterine device (IUD) for $1.1 billion.